logo

For the Inventor, By the Inventor

New Haven, CT, United States of America

Bioxcel Therapeutics, Inc.


USPTO Granted Patents = 17


Trademarks = 4

Forward Citations = 64

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Frank Yocca (17 out of 17 patents)

silverMedal David Christian Hanley (14 out of 15 patents)

bronzeMedal Chetan Dalpatbhai Lathia (14 out of 14 patents)

4.  Vasukumar Kakumanu (10 out of 10 patents)

5.  Lavanya Rajachandran (8 out of 8 patents)

6.  Robert Risinger (8 out of 8 patents)

7.  Scott David Barnhart (6 out of 27 patents)

8.  Vasukumar Kakumanu (4 out of 4 patents)

9.  Krishnan Nandabalan (3 out of 18 patents)

10.  Deepa Saini (3 out of 3 patents)

11.  Harsh Negi (3 out of 3 patents)

12.  Sameer Sharma (3 out of 3 patents)

13.  Sameer Sharma (0 patent)


17 patents:

1. 12364683 - Non-sedating dexmedetomidine treatment regimens (2025-07-22),
2. 12138247 - Non-sedating dexmedetomidine treatment regimens (2024-11-12),
3. 12109196 - Non-sedating dexmedetomidine treatment regimens (2024-10-08),
4. 12090140 - Non-sedating dexmedetomidine treatment regimens (2024-09-17),
5. 11998529 - Non-sedating dexmedetomidine treatment regimens (2024-06-04),
6. 11998528 - Non-sedating dexmedetomidine treatment regimens (2024-06-04),
7. 11931340 - Use of sublingual dexmedetomidine for the treatment of agitation (2024-03-19),
8. 11890272 - Non-sedating dexmedetomidine treatment regimens (2024-02-06),
9. 11839604 - Use of sublingual dexmedetomidine for the treatment of agitation (2023-12-12),
10. 11806429 - Film formulations containing dexmedetomidine and methods of producing them (2023-11-07),
11. 11806334 - Non-sedating dexmedetomidine treatment regimens (2023-11-07),
12. 11786508 - Use of sublingual dexmedetomidine for the treatment of agitation (2023-10-17),
13. 11559484 - Film formulations containing dexmedetomidine and methods of producing them (2023-01-24),
14. 11517524 - Film formulations containing dexmedetomidine and methods of producing them (2022-12-06),
15. 11497711 - Film formulations containing dexmedetomidine and methods of producing them (2022-11-15),
Company Overview
Bioxcel Therapeutics, Inc. is a biopharmaceutical company based in New Haven, Connecticut, focused on developing innovative therapies for patients with unmet medical needs. The company specializes in leveraging its proprietary technology platforms to advance drug candidates in areas such as neuroscience and oncology. By integrating artificial intelligence and data analytics into its research processes, Bioxcel aims to enhance the efficiency of drug development and improve patient outcomes through targeted therapeutic solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

17 Patents

#14 in New Haven, CT

#444 in Connecticut

#18,894 in US

#35,918 in the World

New Haven, CT (US)
New Haven, CT, United States of America

Bioxcel Therapeutics, Inc.

Forward Citations = 64

12 inventors:

goldMedal Frank Yocca (17 out of 17 patents)

silverMedal David Christian Hanley (14 out of 15 patents)

bronzeMedal Chetan Dalpatbhai Lathia (14 out of 14 patents)

4.  Vasukumar Kakumanu (10 out of 10 patents)

5.  Lavanya Rajachandran (8 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bioxcel Therapeutics, Inc.. Retrieved from https://idiyas.com/company/bioxcel-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…